InvestorsHub Logo
Followers 58
Posts 10055
Boards Moderated 1
Alias Born 09/21/2016

Re: attilathehunt post# 106413

Sunday, 05/28/2017 4:18:23 PM

Sunday, May 28, 2017 4:18:23 PM

Post# of 458832
Agree, it is not out of the question and politics matter. If a strong additional analysis shows efficacy then it is not a leap to move forward with recognition. When one considers what AD is and the dynamics of demonstrated A2-73 safety performance along with other pre clinical trial evidence the requirements appear to be met. Many unknowns of course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News